Open-Label Extension Study of MCS-2 in the Treatment of Lower Urinary Tract Symptoms (MCS-2-US-c)

NCT01002222 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Lower Urinary Tract Symptoms
Benign Prostatic Hyperplasia

Interventions

DRUG: MCS-2

Sponsor

Health Ever Bio-Tech Co., Ltd.